entertainment -WSS

entertainment

author：knowledge 2025-10-02 12:32:09 - browse：67724

To scientists' surprise in a new study, a common genetic deletion in schizophrenia cases was linked to problems in mitochondria. Adobe

The heritable nature of schizophrenia has been known for about a century. But researchers are still trying to learn how genes that have been linked to an increased risk of the disease actually lead to schizophrenia.

For decades, those genetic underpinnings of schizophrenia have fascinated Jennifer Mulle, an associate professor at the Rutgers Center for Advanced Biotechnology and Medicine. When she was a master’s student in public health, she set out to locate a place in the DNA that held the secrets of the condition. “We did really beautifully, carefully designed studies,” she said. “And there was nothing.”

In the early 2000s, before they knew many genes factor into schizophrenia, researchers were looking for a single gene that would be culpable for the devastating illness. Mulle spent nearly a decade on the hunt, through her Ph.D. program and into her postdoctoral fellowship at Emory University. Under the mentorship of Stephen Warren, who founded the medical school’s department of human genetics and unearthed the genetics of fragile X syndrome, she finally found something.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Change Healthcare cyberattack outage could last weeks

focus

WSS

International team creates first chimeric human

House looks to weaken Medicare negotiation

International team creates first chimeric human

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Scientists unlock the key to scar

Why getting cancer drugs just got harder for rural patients

hotspot

entertainment

explore

In Memoriam: Notable people who died in 2023

Long Covid research funding gets a major boost from NIH

Alkermes shareholders re

Why Eli Lilly’s earnings didn’t quite live up to the hype

Malaria cases in Florida and Texas: Here’s what you need to know

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Supreme Court strikes down use of affirmative action

Long Covid research funding gets a major boost from NIH

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

focus

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Why getting cancer drugs just got harder for rural patients

FogPharma raises $145 million in rare Series E round

Latigo launches with $135 million for Vertex

knowledge

leisure time

focus

focus